Cardiff Oncology
Duke Aku-Harakal has been working as an Accounting Supervisor at Cardiff Oncology since July 2018. Prior to this, Duke worked as a Board Member - Treasurer at Heron Cove Homeowner's Association and served as a Staff Accountant at My Personal CPA and Financial Planner LLC. Duke also held the position of Staff Accountant at Paradise Lua, Inc. Duke holds a Bachelor of Business Administration (B.B.A.) degree in Accounting from Whittier College.
Cardiff Oncology
Cardiff Oncology is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Our goal is to overcome resistance, improve response to treatment and increase overall survival. We are developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.